Merck Sharp & Dohme LLC, known as MSD, is a research-intensive biopharmaceutical company focused on developing medicines and vaccines for humans and animals. Its technical domains include vaccine development, disease prevention, animal health innovation, and biopharmaceutical research, emphasizing a commitment to scientific advancement.
The company has a history of impactful products, such as Streptomycin, an antibiotic that helped reduce tuberculosis deaths by nearly 50% by 1950, and MSD Animal Health, which provides veterinary solutions for public health and food safety globally.
MSD operates with a presence in the United States, Canada, and worldwide, guided by a people-first philosophy and a research-driven approach to addressing health challenges.
